Experiment 534631

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

CAYAPONOSIDE B-2

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismCayaponia tayuya (CUCURBITACEAE)
CitationKONOSHIMA,T: TAKASAKI,M: KOZUKA,M: NAGAO,T: OKABE,H: IRINO,N: NAKASUMI,T: TOKUDA,H: NISHINO,H:. (1995). INHIBITORY EFFECTS OF CURCURBITANE TRITERPENOIDS ON EPSTEIN-BARR VIRUS ACTIVATION AND TWO-STAGE CARCINOGENENSIS OF SKIN TUMOR. II.. 18(2)
Amount utilized
Compound isolated
DiseaseTHIS BIOASSAY IS INTENDED TO PREDICT ANTITUMOR-PROMOTER ACTIVITY IN VIVO.
Dose amount32.0 NANOMOLS
Number23
Qualitative resultWEAK ACTIVITY
AnimalCELL CULTURE
Dose expressionCONC USED